Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Every Six Weeks"'
Autor:
Chi Chang Huang, Te-Hua Liu, Han-Yin Hsu, Mon-Chien Lee, Shiow-Chwen Tsai, Chia-Chia Lee, San-Land Young, Jin-Seng Lin, Yu-Tsai Tu, Tsung-Yu Tsai
Publikováno v:
Microorganisms
Volume 9
Issue 7
Microorganisms, Vol 9, Iss 1466, p 1466 (2021)
Volume 9
Issue 7
Microorganisms, Vol 9, Iss 1466, p 1466 (2021)
Sarcopenia is a condition in which there is a loss of muscle caused by aging and it is one of the most significant factors that affects physical fragility. In recent years, the role of the gut–muscle axis has garnered attention as, along with the g
Autor:
Vegard Heimly Brun, Renate Kollevåg Vik, Lars Hellemo, Benedicte Davidsen, Kenth Johansson, Ruth Selseth, Amund H Eriksen, Michal Kaut
Publikováno v:
Thyroid
Background: After seven decades of levothyroxine (LT4) replacement therapy, dosage adjustment still takes several months. We have developed a decision aid tool (DAT) that models LT4 pharmacometrics and enables patient-tailored dosage. The aim of this
Autor:
Gabriel Ndunguru, A. Gaspar, Martin Fischler, Adebayo Abass, Daniel Madulu, Esther Kabula, David Msola, Janine Rüst, Kurt Schneider, Shamim Daudi
Publikováno v:
Journal of Stored Products Research. 77:55-65
Seven methods for storing maize were tested and compared with traditional storage of maize in polypropylene bags. Twenty farmers managed the experiment under their prevailing conditions for 30 weeks. Stored grain was assessed for damage every six wee
Publikováno v:
International Journal of Orthopaedics Sciences. 2:171-175
Background: The Quebec Task Force classification (QTF) was originally designed to help in making a clinical decision and to aid in determining the prognosis. However, the predictive validity and prognostic significance of the classification was debat
Autor:
Toru Yoshinari, Shigeto Kobayashi
Publikováno v:
Modern Rheumatology. 27:142-149
To investigate the efficacy, safety, and pharmacokinetics of infliximab (IFX) in Japanese patients with active ankylosing spondylitis (AS).In this multicenter open-label study, IFX was infused at 5 mg/kg to 33 Japanese patients with active AS using o
Publikováno v:
International Journal of Research in Dermatology. 5:760
Background: Keloid a benign tumor of the skin is said to be common in Africans, Hispanics and Asians. Triamcinolone acetonide is a known treatment for keloid and patients come to the clinic asking how many times they need to come in for treatment. Th
Publikováno v:
Small Ruminant Research. 110:1-8
Much research has gone into developing a sustainable management tool for haemonchosis, namely the FAMACHA© system, which has been validated by numerous studies worldwide. However, the financial implications on production of implementing this system
Autor:
Lissandro Tarso, Luíse Meurer, Carlos Cauduro Schirmer, Fabíola Schons Meyer, Marta Justina Giotti Cioato
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.24 n.1 2011
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), Volume: 24, Issue: 1, Pages: 55-58, Published: MAR 2011
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.24 n.1 2011
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), Volume: 24, Issue: 1, Pages: 55-58, Published: MAR 2011
INTRODUÇÃO: O N-metil-N-nitrosourea (MNU) tem ação cancerígena direta, induzindo tumores em várias espécies em uma variedade de órgãos, incluindo o estômago de ratos. Tratamento do MNU na água de beber por 25-42 semanas, seletivamente, ind
Autor:
Shomron Ben-Horin, Jean-François Rahier, Peter L. Lakatos, Pierre Ellul, Konstantinnos H. Katsanos, Catherine Reenaers, Gionata Fiorino, Uri Kopylov, Eran Israeli, Edouard Louis, Monica Cesarini, E.V. Tsianos, Gerassimos J. Mantzaris
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:349-357
Patients treated with infliximab for Crohn's disease (CD) frequently require intensified dosage due to loss of response. There are scant data regarding the efficacy of shortening the dosing interval to 6 weeks.
Publikováno v:
International Journal of Research in Orthopaedics. 4:296
Background: Idiopathic congenital talipes equinovarus is a characterized by deformities with lot of ambiguity regarding the forces maintaining the deformity and preventing its correction. The aim of our midterm study is to analyze the functional outc